Litcius/Paper detail

Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial

Joakim Nordanstig, Stefan James, Manne Andersson, Mattias Andersson, Martin Delle, Jan Engström, Torbjörn Fransson, Peter Gillgren, Anna Hilbertson, Tal M. Hörer, Eva Jacobsson, Björn Kragsterman, Johan Lindbäck, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Olle Nelzén, Robert Olin, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Knut Thorbjørnsen, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Mårten Falkenberg

2025The Lancet44 citationsDOI

Topics & Concepts

MedicineIntermittent claudicationClaudicationPaclitaxelRandomized controlled trialEndovascular treatmentSurgeryPhysical therapyArterial diseaseVascular diseaseChemotherapyAneurysmPeripheral Artery Disease ManagementCerebrovascular and Carotid Artery DiseasesAortic aneurysm repair treatments